Save-your-life test for $25,000 draws rich patients — and skeptics
Craig Venter has got a deal for you. For $25,000, he'll sell you a complete genome sequence, a full-body MRI scan, a cardio CT scan, bone densitometry, cognitive testing and...
Home > Reviews
All Stories
Weed, snail venom may replace addictive opioid pain killers
In the wake of mounting overdoses and deaths from the opioid-addiction crisis sweeping the nation, drugmakers are racing to come up with safer painkillers. Companies are highly motivated to create...
Theranos to fire 41 percent of workforce in second round of cuts
Blood-testing startup Theranos Inc. will fire about 41 percent of its employees after months of regulatory setbacks, lawsuits and scrutiny, saying it is paring down to focus on a new...
Disgraced blood-testing company Theranos hires compliance, quality chiefs
Embattled blood-testing startup Theranos Inc. hired two executives to oversee regulatory, quality and compliance standards as the company seeks to reform itself after receiving heavy sanctions from U.S. regulators. Dave...
Theranos CEO’s two-year ban leaves few options to save startup
Theranos Chief Executive Officer Elizabeth Holmes was banned for two years from owning or operating laboratories by U.S. regulators, a devastating blow for the controversial blood-testing startup that's come under...
Pharma group punches back on drug prices as pressure rises
A top pharmaceutical lobbying group will begin a counteroffensive against scrutiny of industry pricing practices, responding to criticism from both major U.S. political parties in a contentious presidential election season....
Theranos corrects tens of thousands of blood-testing results
Blood-testing startup Theranos said it sent doctors and patients tens of thousands of corrected test results and voided two years of data from its devices, a devastating blow for the...
Valeant files annual report, says it will change strategy
Valeant Pharmaceuticals International filed its delayed 2015 annual report in time to meet a self-imposed Friday deadline, saying it will have no additional financial restatements, is in compliance with its...